banner add

Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug

June 11, 2024 0
The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

from NYT > Health https://ift.tt/dTJFvE7
via IFTTT
Tags:

No comments

Subscribe to: Post Comments ( Atom )

Brenna Henn Wanted to Improve Genetic Medicine. Then Her N.I.H. Grant Was Cut.

Brenna Henn had a long-term grant to study the genetic diversity of Africans and people of African descent. Then her N.I.H. funding was cut....

Theme images by PLAINVIEW. Powered by Blogger.